4th Quarter - Report

PFIZER INC. for PFIZER INC.

Firm
Client
Income
—
Expenses
$2,590,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

Trans Pacific Partnership Negotiations US - EU Dialogues (TEC) - market access and regulatory issues Japan Market Access and Regulatory Issues US-Korea Free Trade Agreement Russia market access (no bills) Israel Patent Issues (no bills) APEC Life Sciences Innovation Forum Brazil IP Thailand Compulsory Licensing India IP and market access issues Australian FTA Implementation Special 301 Reform Legislation

LobbyistCovered position, as disclosed
JOSEPH DAMOND —

Contacted: HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); Patent & Trademark Office (PTO); State, Dept of (DOS); Centers For Medicare and Medicaid Services (CMS); SENATE; Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); Commerce, Dept of (DOC)

Health Issues HCR

Health Reform Comparative Effectiveness Research Prescription Drug User Fee Act (PDUFA) Follow on Biologics Medicare Part D Health Care Reform H.R. 1549 The Preservation of Antibiotics for Medical Treatment Act H.R. 2400 - Strategies to Address Antimicrobial Resistance Act H.R. 4213 - Tax Extenders Act H.R. 4489 FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act H.R. 6331 Generating Antibiotic Incentives Now Act of 2010

LobbyistCovered position, as disclosed
JENNIFER DUCK —
JOHN PAUL HALLIWELL —
BRONWEN KAYE —
ANGELA WALKER RIEMER —

Contacted: Food & Drug Administration (FDA); Commerce, Dept of (DOC); Executive Office of the President (EOP); Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); SENATE; Patent & Trademark Office (PTO); HOUSE OF REPRESENTATIVES; State, Dept of (DOS)

Bills named: H.R. 4213 (111th), H.R. 2400 (111th), H.R. 4489 (111th), H.R. 6331 (111th), H.R. 1549 (111th)

Taxation/Internal Revenue Code TAX

Deferral Deferral for active-financing income- extension S. 1203 - R& E Tax Credit Extension and Enhancement H.R. 422 - R&E Tax Credit Extension and Enhancement H.R. 2098 - CFC Look Through Extension

LobbyistCovered position, as disclosed
MARIA CINO —
KEN W COLE —
ANTHONY PRINCIPI —

Contacted: SENATE; Patent & Trademark Office (PTO); Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); Commerce, Dept of (DOC); State, Dept of (DOS)

Bills named: S. 1203 (111th), H.R. 2098 (111th), H.R. 422 (111th)

Medicare/Medicaid MMM

Medicare Prescription Drug Benefit Medicaid Rebates Medicare Coverage Average Manufacturer Price Regulation Patient Protection and Affordable Care Act Implementation

LobbyistCovered position, as disclosed
JENNIFER DUCK —
JOHN PAUL HALLIWELL —
ANGELA WALKER RIEMER —

Contacted: State, Dept of (DOS); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); SENATE; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); Executive Office of the President (EOP); Patent & Trademark Office (PTO); Commerce, Dept of (DOC)

Consumer Issues/Safety/Products CSP

Importation H.R. 759 - The Food, drug and Cosmetic Globalization Act, 1/09 H.R. 1259 - Dextromethorphan Distribution Act 4/09 S. 1383 - Dextromethorphan Abuse Reduction Act 6/09 H.R. 573 - Act to Prohibit the Marketing of Authorized Generic Drugs, 1/09

LobbyistCovered position, as disclosed
JOHN PAUL HALLIWELL —
ANGELA WALKER RIEMER —

Contacted: Patent & Trademark Office (PTO); Centers For Medicare and Medicaid Services (CMS); SENATE; Executive Office of the President (EOP); Food & Drug Administration (FDA); State, Dept of (DOS); Commerce, Dept of (DOC); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Bills named: H.R. 759 (111th), S. 1383 (111th), H.R. 1259 (111th), H.R. 573 (111th)

Copyright/Patent/Trademark CPT

S. 515 - Patent Reform Act of 2009 S. 299 - Expert Patent Courts Pilot Program Act, 1/09 S. 369 - Preserve Access to Affordable Generics, 2/09 Patent Settlements H.R. 1260 - Patent Reform Act, 3/09 H.R. 1706 - Protecting Consumer Access to Generics Drug Act, 3/09

LobbyistCovered position, as disclosed
JENNIFER DUCK —

Contacted: Food & Drug Administration (FDA); SENATE; Commerce, Dept of (DOC); Patent & Trademark Office (PTO); Health & Human Services, Dept of (HHS); Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; State, Dept of (DOS); Centers For Medicare and Medicaid Services (CMS)

Bills named: S. 369 (111th), H.R. 1260 (111th), S. 299 (111th), S. 515 (111th), H.R. 1706 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.